63629-5269 Anastrozole - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

63629-5269

Brand Name:

Anastrozole

Generic Name:

Anastrozole

Dosage Form Name:

Tablet

Administration Route:

Oral

Substances:

Name: Anastrozole

Strength: 1.0

Unit: mg/1

Packages:

Code: 63629-5269-00

Description: 28 TABLET in 1 BOTTLE, PLASTIC (63629-5269-0)

Effective Date: Jan. 5, 2021

Discontinued:

Code: 63629-5269-01

Description: 30 TABLET in 1 BOTTLE (63629-5269-1)

Effective Date: March 21, 2014

Discontinued:

Code: 63629-5269-02

Description: 20 TABLET in 1 BOTTLE (63629-5269-2)

Effective Date: Aug. 13, 2014

Discontinued:

Code: 63629-5269-03

Description: 90 TABLET in 1 BOTTLE (63629-5269-3)

Effective Date: Jan. 26, 2016

Discontinued:

Code: 63629-5269-04

Description: 4 TABLET in 1 BOTTLE (63629-5269-4)

Effective Date: June 20, 2018

Discontinued:

Code: 63629-5269-05

Description: 6 TABLET in 1 BOTTLE (63629-5269-5)

Effective Date: Dec. 1, 2021

Discontinued:

Code: 63629-5269-06

Description: 10 TABLET in 1 BOTTLE (63629-5269-6)

Effective Date: June 25, 2018

Discontinued:

Code: 63629-5269-07

Description: 40 TABLET in 1 BOTTLE (63629-5269-7)

Effective Date: Nov. 20, 2019

Discontinued:

Code: 63629-5269-08

Description: 12 TABLET in 1 BOTTLE (63629-5269-8)

Effective Date: March 6, 2019

Discontinued:

Code: 63629-5269-09

Description: 14 TABLET in 1 BOTTLE (63629-5269-9)

Effective Date: July 7, 2020

Discontinued:

SEER*Rx Category:

Hormonal Therapy

Major Class:

Aromatase Inhibitor

Minor Class:

Orphan Drug Designation:

Status:

In Use